Variation in CYP1A2 Activity and its Clinical Implications: Influence of Environmental Factors and Genetic Polymorphisms
- 9 May 2008
- journal article
- review article
- Published by Informa UK Limited in Pharmacogenomics
- Vol. 9 (5), 625-637
- https://doi.org/10.2217/14622416.9.5.625
Abstract
CYP1A2 is involved in the metabolism of several widely used drugs and endogenous compounds, and in the activation of procarcinogens. Both genetic and environmental factors influence the activity of this enzyme. The current knowledge regarding factors influencing the activity of CYP1A2 is summarized in this review. Substrates, inhibitors and inducers of CYP1A2 activity, as well as phenotyping probes, are discussed. The functional significance and clinical importance of CYP1A2 gene polymorphisms are reviewed and interethnic differences in the distribution of CYP1A2 variant alleles and haplotypes are summarized. Finally, future perspectives for the possible clinical applications of CYP1A2 genotyping are discussed.Keywords
This publication has 118 references indexed in Scilit:
- Interaction between CYP1A2-T2467DELT polymorphism and smoking in adenocarcinoma and squamous cell carcinoma of the lungLung Cancer, 2007
- Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophreniaBritish Journal of Clinical Pharmacology, 2007
- Metabolism of human cytochrome P450 marker substrates in mouse: a strain and gender comparisonXenobiotica, 2004
- Tizanidine is mainly metabolized by cytochrome P450 1A2 in vitroBritish Journal of Clinical Pharmacology, 2004
- Identification of a novel splice‐site mutation in the CYP1A2 geneBritish Journal of Clinical Pharmacology, 2003
- Genotyping of four genetic polymorphisms in the CYP1A2 gene in the Egyptian populationBritish Journal of Clinical Pharmacology, 2003
- Detection of Three Genetic Polymorphisms in the 5′‐Flanking Region and Intron 1 of Human CYP1A2 in the Japanese PopulationJapanese Journal of Cancer Research, 1999
- The Influence of Ethnic Factors and Gender on CYP1A2-Mediated Drug Disposition: A Comparative Study in Caucasian and Chinese Subjects Using Phenacetin as a Marker SubstrateTherapeutic Drug Monitoring, 1996
- CYP1A2 activity, gender and smoking, as variables influencing the toxicity of caffeineBritish Journal of Clinical Pharmacology, 1996
- Evaluation of caffeine as a test drug for CYP1A2, NAT2 and CYP2E1 phenotyping in man by in vivo versus in vitro correlationsPharmacogenetics, 1996